Potomac, MD, United States of America

Zhi-yong Yang

USPTO Granted Patents = 26 

 

Average Co-Inventor Count = 5.1

ph-index = 9

Forward Citations = 225(Granted Patents)


Location History:

  • Ann Arbor, MI (US) (1997 - 2006)
  • Potomac, MD (US) (2006 - 2020)

Company Filing History:


Years Active: 1997-2020

Loading Chart...
Loading Chart...
26 patents (USPTO):

Title: Zhi-yong Yang: A Pioneer in HIV Research and Antibody Development

Introduction

Zhi-yong Yang, based in Potomac, MD, is an influential figure in the field of biomedical research, particularly known for his significant contributions to the development of broadly neutralizing antibodies against HIV-1. With a remarkable record of 26 patents, Yang's innovations are paving the way for advancements in HIV detection and treatment.

Latest Patents

Among Yang's latest patents are groundbreaking inventions focused on broadly neutralizing HIV-1 antibodies that target the CD4-binding site of the envelope protein. One such patent outlines monoclonal neutralizing antibodies that specifically interact with HIV-1 gp120, along with antigen-binding fragments. These patents also encompass nucleic acids encoding the antibodies, associated vectors, and host cells. Methods for detecting HIV utilizing these antibodies have been developed, providing novel approaches to prevent and treat HIV infections. Another associated patent further details VRC07 antibodies that bind to the same critical site on the envelope protein, expanding the arsenal against HIV.

Career Highlights

Yang's career is distinguished by his tenure at prominent institutions, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and the University of Michigan. His work at these organizations has significantly influenced the field of infectious diseases, particularly through the development of therapies aimed at combating HIV.

Collaborations

Throughout his career, Zhi-yong Yang has collaborated with several renowned researchers, notably Gary J. Nabel and John R. Mascola. Together, they have pooled their knowledge and expertise to drive forward innovative research aimed at addressing the challenges presented by HIV.

Conclusion

Zhi-yong Yang's contributions to HIV research through his innovative patents have the potential to change the landscape of treatment and prevention strategies. His persistent efforts to develop effective therapeutic options continue to inspire and impact the scientific community, marking him as a leading innovator in the ongoing fight against HIV.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…